The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue Sarcoma
Clinical trial NCT05839275 · RECRUITING
Trial details
- NCT number
- NCT05839275
- Sponsor
- Fudan University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-08-01
- Primary completion
- 2024-07-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.